This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

Daniel Tobey

DLA Piper

Mar 17, 2023

FDA calls for comments on artificial intelligence in drug manufacturing

By Keo Shaw Bethany Hills Daniel Tobey +1 more...

On March 1, 2023, FDA’s Center for Drug Evaluation and Research (CDER) published a discussion paper on artificial intelligence (AI) in...